Login / Signup

[Antiangiogenic therapy in the surgical treatment of pterygium].

S A MalozhenS V TrufanovD A Krakhmaleva
Published in: Vestnik oftalmologii (2020)
The use of anti-VEGF agents as adjuvant therapy in the surgical treatment of pterygium is a safe method of reducing postoperative inflammation, fibrovascular proliferation and, subsequently, the amount of relapses.
Keyphrases
  • oxidative stress
  • patients undergoing
  • vascular endothelial growth factor
  • signaling pathway
  • endothelial cells
  • replacement therapy